Chemotherapy toxicity and quality of life in older women with advanced or recurrent endometrial cancer: An NRG Oncology - Gynecologic Oncology Group ancillary study

被引：0
|
作者：
Ko, E. M. [1 ]
Java, J. [2 ]
Van Le, L. [3 ]
Schmitz, K. [4 ]
Randall, M. E. [5 ]
Bloss, J. D. [6 ]
Fleming, G. [7 ]
Moore, D. H. [8 ]
Monk, B. J. [9 ]
Muss, H. B. [10 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Gynecol Oncol Grp, Stat & Data Ctr, Buffalo, NY USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Kentucky, Med Ctr, Lexington, KY USA
[6] Astella Pharma, Northbrook, IL USA
[7] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[8] Franciscan Phys Network Gynecol Oncol Specialists, Indianapolis, IN USA
[9] Univ Arizona, Ctr Canc, Phoenix, AZ USA
[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [1] Impact of older age on chemotherapy toxicity and quality of life in women with advanced or recurrent cervical cancer: A NRG Oncology-GOG Ancillary Study.
    Ko, Emily Meichun
    Java, James
    Schmitz, Kathryn
    Randall, Marcus
    Bloss, Jeffrey
    Fleming, Gini F.
    Moore, David H.
    Monk, Bradley J.
    Muss, Hyman B.
    Van Le, Linda
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Chemotherapy Intensity and Toxicity Among Black and White Women With Advanced and Recurrent Endometrial Cancer A Gynecologic Oncology Group Study
    Farley, John H.
    Tian, Chunqiao
    Rose, G. Scott
    Brown, Carol L.
    Birrer, Michael
    Risinger, John I.
    Thigpen, J. Tate
    Fleming, Gini F.
    Gallion, Holly H.
    Maxwell, G. Larry
    CANCER, 2010, 116 (02) : 355 - 361
  • [3] Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study
    Phippen, N. T.
    Secord, A. A.
    Wolf, S.
    Samsa, G.
    Davidson, B.
    Abernethy, A. P.
    Cella, D.
    Havrilesky, L. J.
    Burger, R. A.
    Monk, B. J.
    Leath, C. A., III
    GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 98 - 103
  • [4] The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study
    Sia, Tiffany Y.
    Tew, William P.
    Purdy, Christopher
    Chi, Dennis S.
    Menzin, Andrew W.
    Lovecchio, John L.
    Bookman, Michael A.
    Cohn, David E.
    Teoh, Deanna G.
    Friedlander, Michael
    Bender, David
    Mutch, David G.
    Gershenson, David M.
    Tewari, Krishnansu S.
    Wenham, Robert M.
    Hendrickson, Andrea E. Wahner
    Lee, Roger B.
    Gray, Heidi J.
    Secord, Angeles Alvarez
    Van Le, Linda
    Lichtman, Stuart M.
    GYNECOLOGIC ONCOLOGY, 2023, 173 : 130 - 137
  • [5] A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
    Bender, David
    Sill, Michael W.
    Lankes, Heather A.
    Reyes, Henry D.
    Darus, Christopher J.
    Delmore, James E.
    Rotmensch, Jacob
    Gray, Heidi J.
    Mannel, Robert S.
    Schilder, Jeanne M.
    Hunter, Mark I.
    McCourt, Carolyn K.
    Samuelson, Megan I.
    Leslie, Kimberly K.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 507 - 512
  • [6] Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: Experience from Gynecologic Oncology Group clinical trials
    Farley, J. H.
    Tian, C.
    Rose, G. S.
    Brown, C. L.
    Birrer, M.
    Thigpen, J. T.
    Fleming, G. F.
    Gallion, H. H.
    Maxwell, G. L.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S19 - S19
  • [7] Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
    McMeekin, D. Scott
    Tritchler, David L.
    Cohn, David E.
    Mutch, David G.
    Lankes, Heather A.
    Geller, Melissa A.
    Powell, Matthew A.
    Backes, Floor J.
    Landrum, Lisa M.
    Zaino, Richard
    Broaddus, Russell D.
    Ramirez, Nilsa
    Gao, Feng
    Ali, Shamshad
    Darcy, Kathleen M.
    Pearl, Michael L.
    DiSilvestro, Paul A.
    Lele, Shashikant B.
    Goodfellow, Paul J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 3062 - +
  • [8] The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study
    Rocconi, Rodney P.
    Lankes, Heather A.
    Brady, William E.
    Goodfellow, Paul J.
    Ramirez, Nilsa C.
    Alvarez, Ronald D.
    Creasman, William
    Fernandez, Jose R.
    GYNECOLOGIC ONCOLOGY, 2016, 140 (02) : 264 - 269
  • [9] Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study
    Garcia-Soto, Arlene E.
    Java, James J.
    Neira, Wilberto Nieves
    Pearson, J. Matthew
    Coh, David E.
    Lele, Shashikant B.
    Tewari, Krishnansu S.
    Walker, Joan L.
    Secord, Angeles Alvarez
    Armstrong, Deborah K.
    Copeland, Larry J.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (03) : 484 - 489
  • [10] Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study
    von Gruenigen, Vivian E.
    Huang, Helen Q.
    Beumer, Jan H.
    Lankes, Heather A.
    Tew, William
    Herzog, Thomas
    Hurria, Arti
    Mannel, Robert S.
    Rizack, Tina
    Landrum, Lisa M.
    Rose, Peter G.
    Salani, Ritu
    Bradley, William H.
    Rutherford, Thomas J.
    Higgins, Robert V.
    Secord, Angeles Alvarez
    Fleming, Gini
    GYNECOLOGIC ONCOLOGY, 2017, 144 (03) : 459 - 467
12345